Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.

Saved in:
Bibliographic Details
Title: Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
Authors: Cavalieri, S.1, Perrone, F.2, Miceli, R.3, Ascierto, P.A.4, Locati, L.D.1, Bergamini, C.1, Granata, R.1, Alfieri, S.1, Resteghini, C.1, Galbiati, D.1, Busico, A.2, Paielli, N.2, Patuzzo, R.5, Maurichi, A.5, Gallino, G.5, Ruggeri, R.5, Mariani, L.3, Palla, M.4, Licitra, L.1,6, Bossi, P.1 paolo.bossi@istitutotumori.mi.it
Source: European Journal of Cancer. Jul2018, Vol. 97, p7-15. 9p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2018.04.004